PET imaging methods such as [11C]UCB-J PET can visualize reductions in synaptic vesicle glycoprotein 2A (SV2A) in the hippocampus, suggesting synaptic dysfunction in AD [110]. Here, SV2A is linked to Alzheimer disease.